1
Bioequivalence Study: 2 mg Estradiol Valerate (EV) and 3 mg Dienogest (DNG) Without and With Levomefolate Calcium
Condition(s):Pharmacology, ClinicalLast Updated:August 1, 2016Completed
EV DNG: 18 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
Efficacy and Safety Study of an Oral Contraceptive in Healthy Females
Condition(s):ContraceptionLast Updated:October 1, 2014Completed
3
Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects
Condition(s):ContraceptionLast Updated:December 17, 2014Completed
4
Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters
Condition(s):Pregnancy, UnplannedLast Updated:November 25, 2013Completed
5
Effects of SH T00658ID on Libido
Condition(s):Contraception; LibidoLast Updated:December 30, 2014Completed
6
Study to Investigate Efficacy and Safety of a New Oral Contraceptive
Condition(s):ContraceptionLast Updated:July 15, 2011Completed
7
Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens
Condition(s):Ovulation InhibitionLast Updated:July 15, 2011Completed
8
Qlaira Post-authorization Safety Study Related to Most Common Adverse Events in Mexican Women Who Wish to Avoid Pregnancy
Condition(s):ContraceptionLast Updated:April 29, 2019Completed
9
To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)
Condition(s):ContraceptionLast Updated:July 19, 2013Completed
10
Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache
Condition(s):Oral Contraceptive; Headache; Pelvic PainLast Updated:January 14, 2016Completed